Puma Biotechnology FDA Live Blog – Forbes

Posted: May 24, 2017 at 7:44 pm


Forbes
Puma Biotechnology FDA Live Blog
Forbes
This is a live blog of the meeting of the Food and Drug Administration's meeting regarding neratinib, a breast cancer drug being developed by Puma Biotechnology. The basic questions to be addressed, per my story from Monday. Puma's not applying to sell ...
Why Puma Biotechnology Inc Jumped Higher TodayMotley Fool
Puma Biotechnology Receives FDA Advisory Committee Support for NeratinibBusiness Wire (press release)
Puma Biotechnology (PBYI) PT Raised to $86 at BofA/Merrill LynchStreetInsider.com
ExpertGazette -Equities.com -Finance News Daily -Zacks
all 71 news articles »

Here is the original post:
Puma Biotechnology FDA Live Blog - Forbes

Related Posts